bioRxivImmunologyPreprint
Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection
G. Baldeon Vaca, M. Meyer, A. Cadete, C. J. Hsiao, A. Golding, A. Jeon, E. Jacquinet, E. Azcue, C. M. Guan, X. Sanchez-Felix, C. A. Pietzsch, C. E. Mire, M. A. Hyde, M. E. Comeaux, J. M. Williams, J. C. Sung, A. Carfi, D. K. Edwards, A. Bukreyev, K. Bahl
Abstract
Intranasal vaccination represents a promising approach for preventing disease caused by respiratory pathogens by eliciting a mucosal immune response in the respiratory tract that may act as an early barrier to infection and transmission. This study investigated immunogenicity and protective efficacy of intranasally administered messenger RNA (mRNA)-lipid nanoparticle (LNP) encapsulated vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Syrian golden hamsters. Intranasal mRNA-LNP vaccination systemically induced spike-specific binding (IgG and IgA) and neutralizing antibodies with similar robustness to intramuscular controls. Additionally, intranasal vaccination decreased viral loads in the respiratory tract, reduced lung pathology, and prevented weight loss after SARS-CoV-2 challenge. This is the first study to demonstrate successful immunogenicity and protection against respiratory viral infection by an intranasally administered mRNA-LNP vaccine.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Intranasal self-amplifying RNA SARS-CoV-2 vaccine produces protective respiratory and systemic immunity and prevents viral transmission
M. F. Jennewein, M. D. Schultz, … E. A. Voigt·bioRxiv·Nov 10, 2022
- A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.
T. Bricker, T. Darling, … A. Boon·bioRxiv·Dec 2, 2020
- Intranasal Vaccination with a Lentiviral Vector Strongly Protects against SARS-CoV-2 in Mouse and Golden Hamster Preclinical Models
M.-W. Ku, M. Bourgine, … P. Charneau·bioRxiv·Jul 21, 2020
- An Intranasal OMV-based vaccine induces high mucosal and systemic protecting immunity against a SARS-CoV-2 infection
P. A. van der Ley, A. Zariri, … C. P. Kruiswijk·Frontiers in ImmunologyPeer-reviewed·Dec 17, 2021
- Intranasal Nanoemulsion Adjuvanted S-2P Vaccine Demonstrates Protection in Hamsters and Induces Systemic, Cell-Mediated and Mucosal Immunity in Mice
S. Ganesan, H. Acosta, … V. Bitko·bioRxiv·Mar 22, 2022
- Adjuvanted subunit intranasal vaccine prevents SARS-CoV-2 onward transmission in hamsters
Yongjun Sui, Swagata Kar, … Jay A. Berzofsky·Frontiers in ImmunologyPeer-reviewed·Feb 7, 2025